Literature DB >> 99236

Use of microbiologic and enzymatic assays in studies on the disposition of 2'-deoxycomformycin in the mouse.

W R McConnell, W J Suling, L S Rice, M Shannon, D L Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 99236

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  5 in total

1.  Physiologic model for the pharmacokinetics of 2'deoxycoformycin in normal and leukemic mice.

Authors:  F G King; R L Dedrick
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

Review 2.  Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

Authors:  R I Glazer
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Deoxycoformycin: neurological toxicity.

Authors:  P P Major; R P Agarwal; D W Kufe
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.

Authors:  J F Smyth; R M Paine; A L Jackman; K R Harrap; M M Chassin; R H Adamson; D G Johns
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

5.  Animal model for immune dysfunction associated with adenosine deaminase deficiency.

Authors:  A Tedde; M E Balis; S Ikehara; R Pahwa; R A Good; P P Trotta
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.